Heartware International Inc.

(HTWR) Trade

By |

Profile

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device.

Contact Information

Website: www.heartware.com
Email: ctaylor@heartwareinc.com
Main Phone: +1 508 739-0950
Address: 500 Old Connecticut Path
State: MA
City / Town: Framingham
Country: USA
Postal Code: 01701

Issuer Information

Exchange: NGS
CEO: Douglas E. Godshall
Employees: 625
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

Profile

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device.

Contact Information

Website: www.heartware.com
Email: ctaylor@heartwareinc.com
Main Phone: +1 508 739-0950
Address: 500 Old Connecticut Path
State: MA
City / Town: Framingham
Country: USA
Postal Code: 01701

Issuer Information

Exchange: NGS
CEO: Douglas E. Godshall
Employees: 625
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 87.38 52 Wk Low 25.02
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,561,508.00 EPS (TTM) -3.40 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Stephen N. Oesterle 1,000
Jeffrey LaRose 1,000
Robert Stockman 1,000
Timothy J. Barberich 1,000
Last 10 Sell Shares
Mark Strong 1,000
Mark Strong 1,000
Peter F. McAree 1,000
James Schuermann 1,000
James Schuermann 1,000
Mark Strong 1,000
Mark Strong 1,000
James Schuermann 1,000
James Schuermann 1,000
Lawrence J. Knopf 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 58 58 58 58
Low Target Price Estimate 44 44 44 44
Mean Target Price Estimate 55.67 55.67 55.67 55.67
Standard Deviation 5.72 5.72 5.72 5.72
Date of Most Recent Estimate 08/12/16 08/12/16 08/12/16 08/12/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 6 6
Moderate Buy 0 0 1 1
Hold 8 10 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.6 2.67 2 1.92